Core Viewpoint - The World Health Organization (WHO) announced that there is no scientific evidence linking the use of acetaminophen (Tylenol) during pregnancy to autism in children, countering claims made by the Trump administration [1] Company Summary - Kenvue (KVUE.US), the manufacturer of Tylenol, experienced a stock price drop of over 7% following the Trump administration's concerns regarding autism risk associated with the drug [1] - Following the WHO's clarification, Kenvue's stock price has gradually recovered [1] Industry Summary - The European Medicines Agency (EMA) also stated that there is currently no evidence linking autism to acetaminophen [1] - WHO emphasized that the causes of autism may involve multiple factors and reiterated that substantial scientific evidence shows no link between vaccines and autism [1] - Previous studies claiming a connection between vaccines and autism have been discredited, according to WHO [1]